Clinic, Manufacturing, Provider and Referral

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinic

Manufacturing

Provider

Referral

The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation

FDA Law Blog

SEPTEMBER 29, 2021

The 340B program, authorized under Section 340B of the Public Health Services Act and administered by HRSA, imposes a ceiling price on pharmaceutical manufacturer sales to “covered entities,” which are certain health clinics that receive federal funding and certain types of safety net hospitals to provide them drugs at lower prices.

Manufacturing

Manufacturing Government Referral Provider

Primary care clinics changes in abortion care after participation in the 2022-23 ExPAND Mifepristone Learning Collaborative [Women's health]

Annals of Family Medicine

NOVEMBER 20, 2024

Context: The ExPAND Mifepristone (ExPAND) learning collaborative is a year-long program focused on growing the pool of abortion providers by integrating medication abortion into primary care. Objectives: 1) Participating clinics begin to provide mifepristone for early pregnancy loss (EPL) and/or abortion care.

Primary Care

Primary Care Clinic Referral Provider

Primary Care Digest

The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation

Primary care clinics changes in abortion care after participation in the 2022-23 ExPAND Mifepristone Learning Collaborative [Women's health]

Stay Connected